These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 20167930)

  • 1. Lung endothelial dysfunction in congestive heart failure: role of impaired Ca2+ signaling and cytoskeletal reorganization.
    Kerem A; Yin J; Kaestle SM; Hoffmann J; Schoene AM; Singh B; Kuppe H; Borst MM; Kuebler WM
    Circ Res; 2010 Apr; 106(6):1103-16. PubMed ID: 20167930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sildenafil preserves lung endothelial function and prevents pulmonary vascular remodeling in a rat model of diastolic heart failure.
    Yin J; Kukucka M; Hoffmann J; Sterner-Kock A; Burhenne J; Haefeli WE; Kuppe H; Kuebler WM
    Circ Heart Fail; 2011 Mar; 4(2):198-206. PubMed ID: 21216837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary endothelial dysfunction: hypertension and heart failure.
    Boulanger CM
    J Mol Cell Cardiol; 1999 Jan; 31(1):39-49. PubMed ID: 10072714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium-independent release of endothelial nitric oxide in the arteriolar network: onset during rapid juvenile growth.
    Nurkiewicz TR; Boegehold MA
    Microcirculation; 2004 Sep; 11(6):453-62. PubMed ID: 15371127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of endothelium-derived hyperpolarizing factor is augmented in monocrotaline-induced pulmonary hypertension of rat lungs.
    Morio Y; Homma N; Takahashi H; Yamamoto A; Nagaoka T; Sato K; Muramatsu M; Fukuchi Y
    J Vasc Res; 2007; 44(4):325-35. PubMed ID: 17438361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
    Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
    Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Na+/H+ exchanger is required for hyperglycaemia-induced endothelial dysfunction via calcium-dependent calpain.
    Wang S; Peng Q; Zhang J; Liu L
    Cardiovasc Res; 2008 Nov; 80(2):255-62. PubMed ID: 18591204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S; Long CL; Wang RH; Wang H
    Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noradrenaline-induced increases in calcium and tension in skeletal muscle conductance and resistance arteries from rats with post-infarction heart failure.
    Trautner S; Amtorp O; Boesgaard S; Andersen CB; Galbo H; Haunsoe S; Sheykhzade M
    Eur J Pharmacol; 2006 May; 537(1-3):143-54. PubMed ID: 16626691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary vascular endothelial growth factor and nitric oxide interaction during total cardiopulmonary bypass in neonatal pigs.
    Serraf A; Aznag H; Baudet B; Détruit H; Séccatore F; Mazmanian MG; Planché C
    J Thorac Cardiovasc Surg; 2003 May; 125(5):1050-7. PubMed ID: 12771878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clopidogrel improves endothelial function and NO bioavailability by sensitizing adenylyl cyclase in rats with congestive heart failure.
    Schäfer A; Fraccarollo D; Pförtsch S; Loch E; Neuser J; Vogt C; Bauersachs J
    Basic Res Cardiol; 2011 May; 106(3):485-94. PubMed ID: 21287353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-2 protects against endothelial dysfunction induced by high glucose levels in rats.
    Qian LB; Wang HP; Qiu WL; Huang H; Bruce IC; Xia Q
    Vascul Pharmacol; 2006 Dec; 45(6):374-82. PubMed ID: 16837248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic decrease in flow contributes to heart failure-induced endothelial dysfunction in rats.
    Devaux C; Iglarz M; Richard V; Mulder P; Henrion D; Renet S; Henry JP; Thuillez C
    Clin Exp Pharmacol Physiol; 2004; 31(5-6):302-5. PubMed ID: 15191402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of peripheral endothelial dysfunction by protein tyrosine phosphatase inhibitors in heart failure.
    Vercauteren M; Remy E; Devaux C; Dautreaux B; Henry JP; Bauer F; Mulder P; Hooft van Huijsduijnen R; Bombrun A; Thuillez C; Richard V
    Circulation; 2006 Dec; 114(23):2498-507. PubMed ID: 17101854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of nitric oxide-producing and -degrading pathways in coronary endothelial dysfunction in chronic kidney disease.
    Tatematsu S; Wakino S; Kanda T; Homma K; Yoshioka K; Hasegawa K; Sugano N; Kimoto M; Saruta T; Hayashi K
    J Am Soc Nephrol; 2007 Mar; 18(3):741-9. PubMed ID: 17267746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled nitric oxide versus aerosolized iloprost for the treatment of pulmonary hypertension with left heart disease.
    Yin N; Kaestle S; Yin J; Hentschel T; Pries AR; Kuppe H; Kuebler WM
    Crit Care Med; 2009 Mar; 37(3):980-6. PubMed ID: 19237907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pioglitazone, a PPARgamma agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats.
    Majithiya JB; Paramar AN; Balaraman R
    Cardiovasc Res; 2005 Apr; 66(1):150-61. PubMed ID: 15769458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large-conductance K+ channel opener CGS7184 as a regulator of endothelial cell function.
    Wrzosek A; Łukasiak A; Gwóźdź P; Malińska D; Kozlovski VI; Szewczyk A; Chlopicki S; Dołowy K
    Eur J Pharmacol; 2009 Jan; 602(1):105-11. PubMed ID: 19028489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ramipril improves nitric oxide availability in hypertensive rats with failing hearts after myocardial infarction.
    Linz W; Itter G; Dobrucki LW; Malinski T; Wiemer G
    J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):180-5. PubMed ID: 14608524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosuvastatin reduces platelet activation in heart failure: role of NO bioavailability.
    Schäfer A; Fraccarollo D; Eigenthaler M; Tas P; Firnschild A; Frantz S; Ertl G; Bauersachs J
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1071-7. PubMed ID: 15761193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.